Clinical Trial Update: Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant Glioma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating Carmustine implants with O6-benzylguanine in children with recurrent malignant glioma. The study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• GLIADEL wafer (carmustine)
• O6-Benzylguanine (O6-Benzylguanine)

Snippet

Sponsor: Pediatric Brain Tumor Consortium | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: TERMINATED